Role of K‑Loop Cysteine Residues in the Marburg Virus Protein VP24–Human Keap1 Complex

Role of K‑Loop Cysteine Residues in the Marburg Virus Protein VP24–Human Keap1 Complex

Bibliographic Details
Main Authors:	Nisha Bhattarai, Bernard S. Gerstman, Prem P. Chapagain
Format:	Article
Language:	English
Published:	American Chemical Society 2018-12-01
Series:	ACS Omega
Online Access:	http://dx.doi.org/10.1021/acsomega.8b02386

Similar Items

Mutation of Hydrophobic Residues in the C-Terminal Domain of the Marburg Virus Matrix Protein VP40 Disrupts Trafficking to the Plasma Membrane
by: Kaveesha J. Wijesinghe, et al.
Published: (2020-04-01)

The Marburg Virus VP24 Protein Interacts with Keap1 to Activate the Cytoprotective Antioxidant Response Pathway
by: Megan R. Edwards, et al.
Published: (2014-03-01)

Cysteine Mutations in the Ebolavirus Matrix Protein VP40 Promote Phosphatidylserine Binding by Increasing the Flexibility of a Lipid-Binding Loop
by: Kristen A. Johnson, et al.
Published: (2021-07-01)

Domain rearrangement and denaturation in Ebola virus protein VP40
by: Rudramani Pokhrel, et al.
Published: (2018-12-01)

PI(4,5)P2 binding sites in the Ebola virus matrix protein VP40 modulate assembly and budding
by: Kristen A. Johnson, et al.
Published: (2024-03-01)

Marburg Virus VP30 Is Required for Transcription Initiation at the Glycoprotein Gene
by: Megan R. Edwards, et al.
Published: (2022-10-01)

Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers
by: William Wan, et al.
Published: (2020-10-01)

Cheminformatics Strategies Unlock Marburg Virus VP35 Inhibitors from Natural Compound Library
by: Isra M. Alsaady, et al.
Published: (2023-08-01)

Modular mimicry and engagement of the Hippo pathway by Marburg virus VP40: Implications for filovirus biology and budding.
by: Ziying Han, et al.
Published: (2020-01-01)

Distinctive Features of the XBB.1.5 and XBB.1.16 Spike Protein Receptor-Binding Domains and Their Roles in Conformational Changes and Angiotensin-Converting Enzyme 2 Binding
by: Tej Sharma, et al.
Published: (2023-08-01)

Structural and Dynamical Basis of VP35-RBD Inhibition by Marine Fungi Compounds to Combat Marburg Virus Infection
by: Abdullah S. Alawam, et al.
Published: (2024-01-01)

Ebola and Marburg virus VP35 coiled-coil validated as antiviral target by tripartite split-GFP complementation
by: Luca Zinzula, et al.
Published: (2022-11-01)

Cysteine residues in the major capsid protein, Vp1, of the JC virus are important for protein stability and oligomer formation.
by: Shintaro Kobayashi, et al.
Published: (2013-01-01)

Etymologia: Marburg Virus
by: Ronnie Henry, et al.
Published: (2017-10-01)

Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism.
by: Shridhar Bale, et al.
Published: (2012-09-01)

Marburg Virus and Monkeypox Virus: The Concurrent Outbreaks in Ghana and the lesson learned from the Marburg Virus Containment
by: Ranjit Sah, et al.
Published: (2022-12-01)

Marburg virus outbreaks in Africa
by: Ibrahim Idris, et al.
Published: (2023-07-01)

Pathogenicity and virulence of Marburg virus
by: Mehedy Hasan Abir, et al.
Published: (2022-12-01)

Marburg virus and the disease it causes
by: Vladimir A. Markin
Published: (2022-12-01)

A computerized pharmaceutical repurposing approach reveals Semicochliodinol B synthesized from Chrysosporium merdarium as a viable therapeutic contender for Marburg virus's VP35 and VP40 proteins
by: Mahamudul Hasan, et al.
Published: (2022-01-01)

Tanzania - The new habitat of Marburg virus
by: Fatema Hasan Kaifa, et al.
Published: (2023-06-01)

Studies of Reservoir Hosts for Marburg Virus
by: Robert Swanepoel, et al.
Published: (2007-12-01)

Pygmy Populations Seronegative for Marburg Virus
by: Matthias Borchert, et al.
Published: (2005-01-01)

Postexposure Treatment of Marburg Virus Infection
by: Thomas W. Geisbert, et al.
Published: (2010-07-01)

Marburg Virus Reverse Genetics Systems
by: Kristina Maria Schmidt, et al.
Published: (2016-06-01)

Marburg virus structure revealed in detail.
by: Richard Robinson
Published: (2011-11-01)

Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress.
by: Jingjing Liang, et al.
Published: (2017-01-01)

A Conserved Tryptophan in the Ebola Virus Matrix Protein C-Terminal Domain Is Required for Efficient Virus-Like Particle Formation
by: Kristen A. Johnson, et al.
Published: (2020-05-01)

Correction: Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress.
by: Jingjing Liang, et al.
Published: (2017-07-01)

Update on the Phylodynamic and Genetic Variability of Marburg Virus
by: Fabio Scarpa, et al.
Published: (2023-08-01)

An introduction to the Marburg virus vaccine consortium, MARVAC.
by: Robert W Cross, et al.
Published: (2022-10-01)

An introduction to the Marburg virus vaccine consortium, MARVAC
by: Robert W. Cross, et al.
Published: (2022-10-01)

Forty-Five Years of Marburg Virus Research
by: Kristina Brauburger, et al.
Published: (2012-10-01)

Structural insight into Marburg virus nucleoprotein–RNA complex formation
by: Yoko Fujita-Fujiharu, et al.
Published: (2022-03-01)

Development of an Immunochromatography Assay to Detect Marburg Virus and Ravn Virus
by: Katendi Changula, et al.
Published: (2023-11-01)

The Ebola Virus Interferon Antagonist VP24 Undergoes Active Nucleocytoplasmic Trafficking
by: Angela R. Harrison, et al.
Published: (2021-08-01)

Preparation of Class Y Immunoglobulins that Neutralize the Marburg Virus
by: O. A. Polezhaeva, et al.
Published: (2021-02-01)

Marburg Virus Outbreak in Equatorial Guinea: Need for Speed
by: Kengo Nathan Ezie, et al.
Published: (2024-01-01)

CRISPR-based biosensor for the detection of Marburg and Ebola virus
by: Irkham Irkham, et al.
Published: (2024-02-01)

Marburg Virus Disease in Tanzania: The most recent outbreak
by: Novonil Deb, et al.
Published: (2023-06-01)